US stocks MEIP rose more than 33% today, and its market value rose to US$41.24 million

 MEI Pharma (NASDAQ code: MEIP) rose more than 33% today, with a market value of $412.31 million.

Earlier news, Titan Partners Group and the cryptocurrency investment company GSR are jointly leading the strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ code: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, there are over $100 million in funding commitments for this project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.